Lv351
280 积分 2023-10-16 加入
Inverse probability weighted Bayesian dynamic borrowing for estimation of marginal treatment effects with application to hybrid control arm oncology studies
1天前
已完结
rdborrow: an R package for causal inference incorporating external controls in randomized controlled trials with longitudinal outcomes
1天前
已完结
Application of complete N-of-1 trial design in bioequivalence-bIosimilar drug development
1天前
已完结
Why “Minimal Clinically Important Difference” for Interpreting the Magnitude of the Treatment Effect Is Not Useful
1天前
已完结
Toward Better Practice of Covariate Adjustment in Analyzing Randomized Clinical Trials
6天前
已完结
Application of Bayesian approaches in drug development: starting a virtuous cycle
11天前
已完结
Optimal adaptive promising zone designs
12天前
已完结
CUSUMIN Combination: A Cumulative Sum Interval Design for Phase I Cancer Drug‐Combination Trials
13天前
已完结
Reimagining optimization of clinical trials efficiency through use of statistical innovation, technology and non-standard data sources
19天前
已完结
Confirmatory Evidence Used in Non‐Oncologic Rare Disease New Molecular Entity Marketing Applications Approved by FDA, 2020–2023
22天前
已完结
皖公网安备34019202002308
